NPI: 1093809824 · SAINT JOHNS, MI 48879 · Critical Access Hospital · NPI assigned 10/03/2006
Authorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
| Authorized Official | RUSSIAN, MISTY (SUPERVISOR. PROVIDER ENROLLMENT) |
| Parent Organization | SPARROW HEALTH SYSTEM |
| NPI Enumeration Date | 10/03/2006 |
Other providers sharing the same authorized official: RUSSIAN, MISTY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,688 | $722K |
| 2019 | 20,981 | $689K |
| 2020 | 19,484 | $917K |
| 2021 | 29,054 | $1.39M |
| 2022 | 33,323 | $1.68M |
| 2023 | 37,867 | $1.82M |
| 2024 | 27,937 | $1.46M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,903 | 6,325 | $2.51M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,515 | 6,144 | $1.50M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,917 | 7,575 | $1.19M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7,487 | 6,447 | $644K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,613 | 4,152 | $562K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,297 | 2,211 | $412K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,894 | 1,612 | $218K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,935 | 3,354 | $159K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,807 | 1,751 | $150K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,431 | 1,961 | $146K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,010 | 3,542 | $145K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,177 | 1,146 | $143K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,208 | 1,014 | $134K |
| 71046 | Radiologic examination, chest; 2 views | 2,360 | 2,278 | $107K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,982 | 1,925 | $79K |
| 71045 | Radiologic examination, chest; single view | 1,305 | 1,260 | $69K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,557 | 1,304 | $62K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 383 | 374 | $52K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 525 | 520 | $50K |
| 80061 | Lipid panel | 2,452 | 2,445 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,274 | 1,242 | $29K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 749 | 326 | $20K |
| 76830 | Ultrasound, transvaginal | 272 | 269 | $19K |
| 80053 | Comprehensive metabolic panel | 11,658 | 10,579 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,118 | 4,042 | $15K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 407 | 405 | $14K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,058 | 3,673 | $12K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 476 | 238 | $12K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 80 | 79 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,373 | 1,369 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,971 | 12,446 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,093 | 2,764 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 582 | 563 | $8K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 68 | 68 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,404 | 2,383 | $6K |
| Q3014 | Telehealth originating site facility fee | 302 | 278 | $6K |
| 97162 | 129 | 125 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 98 | 95 | $6K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 81 | 81 | $5K |
| 94060 | 30 | 30 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 686 | 686 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 75 | 75 | $5K |
| 93976 | 66 | 64 | $4K | |
| 82607 | 939 | 937 | $4K | |
| 86900 | 493 | 487 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,184 | 1,155 | $4K |
| 93971 | 43 | 41 | $3K | |
| 90686 | 300 | 298 | $3K | |
| 86850 | 895 | 885 | $3K | |
| 84439 | 1,182 | 1,166 | $3K | |
| 86803 | 531 | 530 | $3K | |
| 85027 | 2,000 | 1,873 | $2K | |
| 82728 | 529 | 528 | $2K | |
| 86780 | 413 | 413 | $2K | |
| 84702 | 662 | 474 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 1,740 | 1,538 | $2K |
| 0124A | 73 | 73 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,804 | 3,507 | $2K |
| 83550 | 646 | 642 | $2K | |
| G0378 | Hospital observation service, per hour | 42 | 39 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 144 | 142 | $2K |
| 82652 | 109 | 109 | $2K | |
| 87631 | 395 | 393 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 668 | 633 | $1K |
| 90677 | 15 | 15 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 113 | 111 | $1K |
| 83735 | 2,917 | 2,627 | $1K | |
| 83540 | 658 | 654 | $1K | |
| 73630 | 161 | 158 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,213 | 2,115 | $1K |
| 86140 | 4,713 | 4,414 | $1K | |
| 82043 | 478 | 476 | $983.87 | |
| 97161 | 13 | 13 | $910.29 | |
| 87340 | 316 | 316 | $893.76 | |
| 82570 | 471 | 464 | $880.95 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 109 | 109 | $869.87 |
| 83880 | 746 | 704 | $834.74 | |
| 84703 | 4,266 | 4,019 | $684.82 | |
| 81001 | 4,688 | 4,430 | $643.59 | |
| 72110 | 36 | 36 | $588.01 | |
| 85610 | 2,768 | 2,569 | $510.47 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 35 | 35 | $476.00 |
| 85652 | 1,508 | 1,454 | $461.14 | |
| 80076 | 1,571 | 1,501 | $432.51 | |
| 90656 | 28 | 28 | $417.75 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 25 | 25 | $407.17 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 758 | 748 | $404.30 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,482 | 3,320 | $394.80 |
| 83690 | 3,179 | 2,932 | $376.74 | |
| 86901 | 481 | 476 | $250.93 | |
| 85730 | 2,466 | 2,362 | $248.40 | |
| 81003 | 2,032 | 1,950 | $243.55 | |
| 73130 | 24 | 24 | $196.19 | |
| 83605 | 3,986 | 3,665 | $188.75 | |
| 84484 | 2,610 | 2,353 | $188.73 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,431 | 1,370 | $187.83 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 188 | 163 | $186.88 |
| 82746 | 41 | 41 | $178.66 | |
| 73564 | 14 | 14 | $161.18 | |
| 87077 | 247 | 237 | $88.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 706 | 605 | $74.21 |
| 85379 | 482 | 469 | $68.69 | |
| 73610 | 12 | 12 | $65.51 | |
| 87420 | 292 | 284 | $35.34 | |
| 81002 | 38 | 38 | $34.45 | |
| 87040 | 171 | 166 | $32.09 | |
| 87186 | 99 | 97 | $31.55 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,496 | 1,385 | $29.07 |
| 87486 | 13 | 13 | $25.89 | |
| 87581 | 13 | 13 | $25.89 | |
| 85007 | 65 | 62 | $16.62 | |
| 91312 | 69 | 69 | $1.00 | |
| 90670 | 14 | 14 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 261 | 195 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 162 | 146 | $0.00 |
| 90461 | 96 | 96 | $0.00 | |
| 82948 | 27 | 24 | $0.00 | |
| 90715 | 42 | 42 | $0.00 | |
| 90734 | 12 | 12 | $0.00 | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 12 | 12 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 26 | 25 | $0.00 |
| 94729 | 24 | 24 | $0.00 | |
| 87210 | 12 | 12 | $0.00 | |
| 94726 | 27 | 27 | $0.00 | |
| 90648 | 14 | 14 | $0.00 | |
| 96376 | 328 | 236 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 66 | 61 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 307 | 301 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 15 | 13 | $0.00 |
| 96127 | 13 | 13 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 14 | 12 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 19 | 19 | $0.00 |